Last updated: 28 May 2021 at 6:02pm EST

Christopher Alafi Net Worth




The estimated Net Worth of Christopher D Alafi is at least $10.4 Milión dollars as of 27 May 2021. Christopher Alafi owns over 47,325 units of Intra-Cellular Therapies Inc stock worth over $7,098,400 and over the last 10 years he sold ITCI stock worth over $3,017,186. In addition, he makes $240,737 as Independent Director at Intra-Cellular Therapies Inc.

Christopher Alafi ITCI stock SEC Form 4 insiders trading

Christopher has made over 21 trades of the Intra-Cellular Therapies Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently he sold 47,325 units of ITCI stock worth $1,897,733 on 27 May 2021.

The largest trade he's ever made was buying 625,000 units of Intra-Cellular Therapies Inc stock on 11 March 2015 worth over $15,000,000. On average, Christopher trades about 39,170 units every 41 days since 2014. As of 27 May 2021 he still owns at least 95,000 units of Intra-Cellular Therapies Inc stock.

You can see the complete history of Christopher Alafi stock trades at the bottom of the page.





Christopher Alafi biography

Dr. Christopher D. Alafi Ph.D. is an Independent Director of Intra-Cellular Therapies, Inc. Dr. Alafi became a director of the Company following the Merger that occurred in August 2013 and has served on the board of directors of ITI since January 2013. Dr. Alafi has been a Managing Partner of Alafi Capital Company, LLC, a venture capital firm and a principal stockholder of the Company, since 1995. He was previously a Physiology and Anatomy teacher at Santa Monica College, a visiting scholar in the Department of Chemistry at Stanford University and a researcher at DNAX. Dr. Alafi previously served as a director of ISTO Technologies, Coley Pharmaceutical Group, Inc., CyberGold, Inc. and Stereotaxis, Inc. Dr. Alafi received a B.A. in Biology from Pomona College and a D.Phil. in Biochemistry from the University of Oxford.

What is the salary of Christopher Alafi?

As the Independent Director of Intra-Cellular Therapies Inc, the total compensation of Christopher Alafi at Intra-Cellular Therapies Inc is $240,737. There are 13 executives at Intra-Cellular Therapies Inc getting paid more, with Sharon Mates having the highest compensation of $4,724,560.



How old is Christopher Alafi?

Christopher Alafi is 56, he's been the Independent Director of Intra-Cellular Therapies Inc since 2014. There are 12 older and 4 younger executives at Intra-Cellular Therapies Inc. The oldest executive at Intra-Cellular Therapies Inc is Richard Lerner, 81, who is the Independent Director.

What's Christopher Alafi's mailing address?

Christopher's mailing address filed with the SEC is 8 Admiral Dr, Emeryville, CA 94608, USA.

Insiders trading at Intra-Cellular Therapies Inc

Over the last 11 years, insiders at Intra-Cellular Therapies Inc have traded over $77,703,646 worth of Intra-Cellular Therapies Inc stock and bought 3,068,522 units worth $52,322,638 . The most active insiders traders include Rory B Riggs, Joel S Marcus a Christopher D Alafi. On average, Intra-Cellular Therapies Inc executives and independent directors trade stock every 17 days with the average trade being worth of $2,787,280. The most recent stock trade was executed by Sharon Mates on 29 August 2024, trading 70,000 units of ITCI stock currently worth $891,100.



What does Intra-Cellular Therapies Inc do?

intra-cellular therapies is a company based out of 3960 broadway, new york, new york, united states.



What does Intra-Cellular Therapies Inc's logo look like?

Intra-Cellular Therapies Inc logo

Complete history of Christopher Alafi stock trades at Intra-Cellular Therapies Inc

Dátum
#
Spoločnosť
Človek
Trans.
Transakcia
Počet akcií Cena za akciu Celková cena Počet akcií po Zdroj
27 May 2021 Christopher D Alafi
Riaditeľ
Predaj 47,325 $40.10 $1,897,733
27 May 2021
95,000
21 May 2021 Christopher D Alafi
Riaditeľ
Predaj 27,675 $40.45 $1,119,454
21 May 2021
142,325
14 Sep 2020 Christopher D Alafi
Riaditeľ
Kúpa 49,500 $29.60 $1,465,200
14 Sep 2020
4,743,770
11 Sep 2020 Christopher D Alafi
Riaditeľ
Kúpa 21,000 $28.08 $589,680
11 Sep 2020
4,694,270
10 Sep 2019 Christopher D Alafi
Riaditeľ
Kúpa 485,000 $10.26 $4,976,100
10 Sep 2019
4,673,270
30 Aug 2019 Christopher D Alafi
Riaditeľ
Kúpa 125,000 $8.52 $1,065,000
30 Aug 2019
4,188,270
12 Jun 2019 Christopher D Alafi
Riaditeľ
Kúpa 170,000 $11.73 $1,994,100
12 Jun 2019
170,000
14 May 2019 Christopher D Alafi
Riaditeľ
Kúpa 100,000 $12.56 $1,256,000
14 May 2019
4,053,270
29 Dec 2017 Christopher D Alafi
Riaditeľ
Kúpa 1,001 $14.48 $14,494
29 Dec 2017
745,467
22 Nov 2017 Christopher D Alafi
Riaditeľ
Kúpa 10,000 $15.55 $155,500
22 Nov 2017
744,466
29 Sep 2017 Christopher D Alafi
Riaditeľ
Kúpa 258,065 $15.50 $4,000,008
29 Sep 2017
3,953,270
6 Dec 2016 Christopher D Alafi
Riaditeľ
Kúpa 65,000 $16.27 $1,057,550
6 Dec 2016
3,695,205
14 Nov 2016 Christopher D Alafi
Riaditeľ
Kúpa 34,000 $14.50 $493,000
14 Nov 2016
3,630,205
29 Feb 2016 Christopher D Alafi
Riaditeľ
Kúpa 100,000 $29.70 $2,970,000
29 Feb 2016
728,828
29 Feb 2016 Christopher D Alafi
Riaditeľ
Kúpa 100,000 $29.70 $2,970,000
29 Feb 2016
728,828
11 Mar 2015 Christopher D Alafi
Riaditeľ
Kúpa 625,000 $24.00 $15,000,000
11 Mar 2015
627,604
1 Dec 2014 Christopher D Alafi
Riaditeľ
Kúpa 1,422 $14.75 $20,975
1 Dec 2014
3,596,205
28 Nov 2014 Christopher D Alafi
Riaditeľ
Kúpa 35,000 $14.75 $516,250
28 Nov 2014
3,594,783
19 Nov 2014 Christopher D Alafi
Riaditeľ
Kúpa 1,034 $14.25 $14,735
19 Nov 2014
3,559,783
14 Nov 2014 Christopher D Alafi
Riaditeľ
Kúpa 3,664 $14.26 $52,249
14 Nov 2014
3,558,749
11 Nov 2014 Christopher D Alafi
Riaditeľ
Kúpa 12,200 $15.34 $187,148
11 Nov 2014
3,555,085


Intra-Cellular Therapies Inc executives and stock owners

Intra-Cellular Therapies Inc executives and other stock owners filed with the SEC include: